Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008

Heart failure (HF) patients increasingly receive device therapy, either an implantable cardioverter defibrillator (ICD) or a biventricular pacemaker, also called cardiac resynchronization therapy (CRT), or a CRT device with an ICD (CRT‐D). However, epidemiological data on the use of device therapy in Europe are limited.

[1]  M. Cheitlin.  Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events , 2010 .

[2]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[3]  K. Dickstein,et al.  The European cardiac resynchronization therapy survey. , 2009, European heart journal.

[4]  A. Dobson,et al.  Understanding the ‘epidemic of heart failure’: a systematic review of trends in determinants of heart failure , 2009, European journal of heart failure.

[5]  M. Frenneaux,et al.  Implantable Cardioverter Defibrillator Therapy for Primary Prevention of Sudden Cardiac Death after Myocardial Infarction: , 2009, Pacing and clinical electrophysiology : PACE.

[6]  A. De Simone,et al.  Long‐Term Outcomes of CRT‐PM Versus CRT‐D Recipients , 2009, Pacing and clinical electrophysiology : PACE.

[7]  S. Committee.  European cardiac resynchronization therapy survey: rationale and design , 2009, European journal of heart failure.

[8]  A. Waldo.  Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms , 2009 .

[9]  J. Camm,et al.  Successful treatment of heart failure with devices requires collaboration , 2008, European journal of heart failure.

[10]  M. Böhm,et al.  Heart failure with normal left ventricular ejection fraction: what is the evidence? , 2008, Trends in cardiovascular medicine.

[11]  Kevin L. Thomas,et al.  Preventing tomorrow's sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention. , 2008, American heart journal.

[12]  M. Josephson,et al.  A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. , 2008, Journal of the American College of Cardiology.

[13]  Michael Böhm,et al.  Kommentar zu den ESC-Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 , 2008, European journal of heart failure.

[14]  A. Laupacis,et al.  Design and implementation of a population-based registry of Implantable Cardioverter Defibrillators (ICDs) in Ontario. , 2008, Heart rhythm.

[15]  Kevin L. Thomas,et al.  Use of Cardiac Resynchronization Therapy in Patients Hospitalized With Heart Failure , 2008, Circulation.

[16]  W. Abraham,et al.  Comparison of Sudden Cardiac Death in Heart Failure Patients with Cardiac Resynchronization and Defibrillator Therapy (CRT-D) Versus CRT Alone (CRT-P) , 2008 .

[17]  C. O’loughlin,et al.  Need and evolution of need for device therapy in a community heart failure population , 2008, European journal of heart failure.

[18]  Hans L Hillege,et al.  Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). , 2008, Archives of internal medicine.

[19]  Chunliu Zhan,et al.  Cardiac Device Implantation in the United States from 1997 through 2004: A Population-based Analysis , 2007, Journal of General Internal Medicine.

[20]  A. Owen,et al.  Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials , 2007, BMJ : British Medical Journal.

[21]  Ben Vandermeer,et al.  Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. , 2007, JAMA.

[22]  Nick Freemantle,et al.  Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or discharge , 2007, European journal of heart failure.

[23]  K. Swedberg,et al.  International variations in the treatment and co‐morbidity of left ventricular systolic dysfunction: Data from the EuroHeart Failure Survey , 2007, European journal of heart failure.

[24]  J. Camm,et al.  The cost of implantable defibrillators: perceptions and reality. , 2007, European heart journal.

[25]  Jeroen J. Bax,et al.  Cardiac resynchronization therapy in patients with a narrow QRS complex. , 2006, Journal of the American College of Cardiology.

[26]  J. Daubert,et al.  There is plenty of room for cardiac resynchronization therapy devices without back-up defibrillators in the electrical treatment of heart failure. , 2005, Journal of the American College of Cardiology.

[27]  J J Bax,et al.  Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm , 2005, Heart.

[28]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[29]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[30]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[31]  A. Coats,et al.  Life-Years Gained From Defibrillator Implantation: Markedly Nonlinear Increase During 3 Years of Follow-Up and Its Implications , 2004, Circulation.

[32]  N. Freemantle,et al.  The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. , 2003, European heart journal.

[33]  N. Freemantle,et al.  The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment , 2003 .

[34]  D. J. Veldhuisen,et al.  The pharmacological management of heart failure: too many treatments? , 2003 .

[35]  D. V. van Veldhuisen,et al.  The pharmacological management of heart failure: too many treatments? , 2003, European journal of heart failure.

[36]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[37]  H. Crijns,et al.  Differences in drug treatment of chronic heart failure between European countries. , 1999, European heart journal.